Agency Information Collection Activities: Submission for OMB Review; Comment Request, 41488-41497 [2010-17400]
Download as PDF
41488
Federal Register / Vol. 75, No. 136 / Friday, July 16, 2010 / Notices
srobinson on DSKHWCL6B1PROD with NOTICES
an NDMC to enrollees upon denial, in
whole or in part, of an enrollee’s
coverage request. This denial may be
subject to a series of administrative
review levels, involving defined steps
and timeframes. The NDMC was
developed to ensure Medicare enrollees
have access to information needed to
navigate the Medicare beneficiary
appeals process. The NDMC meets
requirements for both Medicare’s
standard and expedited appeals
processes.
Medicare health plans provide an
NDP to enrollees upon denial, in whole
or in part, of payment for a service or
item that the enrollee received. This
denial may be subject to a series of
administrative review levels, involving
defined steps and timeframes. The NDP
was developed to ensure Medicare
enrollees have access to information
needed to navigate the Medicare
beneficiary appeals process. The NDP
meets requirements for Medicare’s
standard appeals process. Form
Number: CMS–10003 (OMB#: 0938–
0829); Frequency: Yearly; Affected
Public: Business or other for-profits and
Not-for-profit institutions; Number of
Respondents: 740; Total Annual
Responses: 1,168,368; Total Annual
Hours: 194,728. (For policy questions
regarding this collection contact
Stephanie Simons at 206–615–2420. For
all other issues call 410–786–1326.)
3. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Federal
Qualification Application (42 CFR
417.140) and Medicare Health Care
Prepayment Plan Application (42 CFR
417.800); Use: The application is the
collection form used to obtain
information to determine if an applicant
meets the regulatory requirements to
enter into a contract with CMS as a
Federal Qualified health maintenance
organization (HMO) or to provide health
benefits to Medicare beneficiaries as a
Medicare Health Care Prepayment Plan
contractor. Form Number: CMS–901A &
901D (OMB#: 0938–0470); Frequency:
Once; Affected Public: Business or other
for-profits and Not-for-profit
institutions; Number of Respondents:
20; Total Annual Responses: 20; Total
Annual Hours: 800. (For policy
questions regarding this collection
VerDate Mar<15>2010
18:00 Jul 15, 2010
Jkt 220001
contact Heidi Arndt at 410–786–1607.
For all other issues call 410–786–1326.)
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS Web site
address at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
To be assured consideration,
comments and recommendations for the
proposed information collections must
be received by the OMB desk officer at
the address below, no later than 5 p.m.
on August 16, 2010.
OMB, Office of Information and
Regulatory Affairs, Attention: CMS
Desk Officer, Fax Number: (202) 395–
6974, E-mail: OIRA_submission
@omb.eop.gov.
Dated: July 9, 2010.
Michelle Shortt,
Director, Regulations Development Group,
Office of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2010–17181 Filed 7–15–10; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: Mandatory Guidelines for
Federal Workplace Drug Testing
Programs (OMB No. 0930–0158)—
Revision
SAMHSA’s Mandatory Guidelines for
Federal Workplace Drug Testing
Programs will request OMB approval for
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
the Federal Drug Testing Custody and
Control Form for Federal agency and
federally regulated drug testing
programs which must comply with the
HHS Mandatory Guidelines for Federal
Workplace Drug Testing Programs (73
FR 71858) dated November 25, 2008,
and for the information provided by
laboratories for the National Laboratory
Certification Program (NLCP).
The Federal Drug Testing Custody
and Control Form (Federal CCF) is used
by all Federal agencies and employers
regulated by the Department of
Transportation to document the
collection and chain of custody of urine
specimens at the collection site, for
laboratories to report results, and for
Medical Review Officers to make a
determination. The current Federal CCF
approved by OMB has a November 30,
2011 expiration date. SAMHSA has
resubmitted the Federal CCF with
revisions to the form for OMB approval.
• The first change is to add a new
item in Step 1 of Copy 1, which lists the
acronyms for the Federal testing
authorities under which the specimen is
collected. The new Step 1 (d) would
read as follows: ‘‘D. Specify Testing
Authority: HHS, NRC, DOT—Specify
DOT Agency: FMCSA, FAA, FRA, FTA,
PHMSA, USCG’’ with a checkbox beside
each agency name.
• The second change is to revise the
Federal CCF Copy 1 to permit use by
Instrumented Initial Test Facility (IITF),
in addition to laboratories.
• The third change is to add the new
drug analytes required by the revised
Guidelines to the Primary Specimen
Report section in Step 5(a) on Copy 1.
The new drug analytes are
methylenedioxymethamphetamine
(MDMA), commonly known as
‘‘ecstasy’’; methyleneamphetamine
(MDA), and
methylenedioxyethylamphetamine
(MDEA). MDA and MDEA are both close
chemical analogues of MDMA.
• The fourth change is to revise the
Medical Review Officer (MRO) reporting
sections on Copy 2 for primary
specimens (Step 6) and for split
specimens (Step 7) to facilitate reporting
in accordance with the Guidelines.
Below is a copy of the revised Federal
CCF:
BILLING CODE 4162–20–P
E:\FR\FM\16JYN1.SGM
16JYN1
VerDate Mar<15>2010
18:00 Jul 15, 2010
Jkt 220001
PO 00000
Frm 00060
Fmt 4703
Sfmt 4725
E:\FR\FM\16JYN1.SGM
16JYN1
41489
EN16JY10.028
srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 75, No. 136 / Friday, July 16, 2010 / Notices
VerDate Mar<15>2010
Federal Register / Vol. 75, No. 136 / Friday, July 16, 2010 / Notices
18:00 Jul 15, 2010
Jkt 220001
PO 00000
Frm 00061
Fmt 4703
Sfmt 4725
E:\FR\FM\16JYN1.SGM
16JYN1
EN16JY10.029
srobinson on DSKHWCL6B1PROD with NOTICES
41490
VerDate Mar<15>2010
18:00 Jul 15, 2010
Jkt 220001
PO 00000
Frm 00062
Fmt 4703
Sfmt 4725
E:\FR\FM\16JYN1.SGM
16JYN1
41491
EN16JY10.030
srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 75, No. 136 / Friday, July 16, 2010 / Notices
VerDate Mar<15>2010
Federal Register / Vol. 75, No. 136 / Friday, July 16, 2010 / Notices
18:00 Jul 15, 2010
Jkt 220001
PO 00000
Frm 00063
Fmt 4703
Sfmt 4725
E:\FR\FM\16JYN1.SGM
16JYN1
EN16JY10.031
srobinson on DSKHWCL6B1PROD with NOTICES
41492
VerDate Mar<15>2010
18:00 Jul 15, 2010
Jkt 220001
PO 00000
Frm 00064
Fmt 4703
Sfmt 4725
E:\FR\FM\16JYN1.SGM
16JYN1
41493
EN16JY10.032
srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 75, No. 136 / Friday, July 16, 2010 / Notices
VerDate Mar<15>2010
Federal Register / Vol. 75, No. 136 / Friday, July 16, 2010 / Notices
18:00 Jul 15, 2010
Jkt 220001
PO 00000
Frm 00065
Fmt 4703
Sfmt 4725
E:\FR\FM\16JYN1.SGM
16JYN1
EN16JY10.033
srobinson on DSKHWCL6B1PROD with NOTICES
41494
VerDate Mar<15>2010
18:00 Jul 15, 2010
Jkt 220001
PO 00000
Frm 00066
Fmt 4703
Sfmt 4725
E:\FR\FM\16JYN1.SGM
16JYN1
41495
EN16JY10.034
srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 75, No. 136 / Friday, July 16, 2010 / Notices
VerDate Mar<15>2010
Federal Register / Vol. 75, No. 136 / Friday, July 16, 2010 / Notices
18:00 Jul 15, 2010
Jkt 220001
PO 00000
Frm 00067
Fmt 4703
Sfmt 4725
E:\FR\FM\16JYN1.SGM
16JYN1
EN16JY10.035
srobinson on DSKHWCL6B1PROD with NOTICES
41496
41497
Federal Register / Vol. 75, No. 136 / Friday, July 16, 2010 / Notices
BILLING CODE 4162–20–C
Prior to an inspection, a laboratory is
required to submit specific information
regarding its laboratory procedures.
Collecting this information prior to an
inspection allows the inspectors to
thoroughly review and understand the
laboratory’s testing procedures before
arriving at the laboratory.
The annual total burden estimates for
the Federal Drug Testing Custody and
Control Form, the NLCP application, the
NLCP inspection checklist, and NLCP
recordkeeping requirements are shown
in the following table.
Burden/
response
(hrs.)
Form/respondent
Number of
responses
Total annual
burden
(hrs.)
7,096,000
7,096,000
7,096,000
7,096,000
3
100
50
567,680
496,720
354,800
354,800
9
300
12,500
........................
........................
1,786,809
Written comments and
recommendations concerning the
proposed information collection should
be sent by August 16, 2010 to: SAMHSA
Desk Officer, Human Resources and
Housing Branch, Office of Management
and Budget, New Executive Office
Building, Room 10235, Washington, DC
20503; due to potential delays in OMB’s
receipt and processing of mail sent
through the U.S. Postal Service,
respondents are encouraged to submit
comments by fax to: 202–395–6974.
Dated: July 12, 2010.
Dennis O. Romero,
Deputy Director, Office of Program Services.
[FR Doc. 2010–17400 Filed 7–15–10; 8:45 am]
BILLING CODE 4162–20–P
VerDate Mar<15>2010
18:00 Jul 15, 2010
Jkt 220001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
Project: Pretesting of Substance Abuse
Prevention and Treatment and Mental
Health Services Communication
Messages—(OMB No. 0930–0196)—
Extension
As the Federal agency responsible for
developing and disseminating
authoritative knowledge about
substance abuse prevention, addiction
treatment, and mental health services
and for mobilizing consumer support
and increasing public understanding to
overcome the stigma attached to
addiction and mental illness, the
Substance Abuse and Mental Health
Services Administration (SAMHSA) is
responsible for development and
dissemination of a wide range of
education and information materials for
E:\FR\FM\16JYN1.SGM
16JYN1
EN16JY10.036
.08
.07
.05
.05
3.00
3.00
250.00
Total ...............................................................................................................................
srobinson on DSKHWCL6B1PROD with NOTICES
Custody and Control Form:
Donor ....................................................................................................................................
Collector ................................................................................................................................
Laboratory .............................................................................................................................
Medical Review Officer .........................................................................................................
Laboratory Application .................................................................................................................
Laboratory Inspection Checklist ..................................................................................................
Laboratory Recordkeeping ..........................................................................................................
Agencies
[Federal Register Volume 75, Number 136 (Friday, July 16, 2010)]
[Notices]
[Pages 41488-41497]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-17400]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and Mental Health Services
Administration (SAMHSA) will publish a summary of information
collection requests under OMB review, in compliance with the Paperwork
Reduction Act (44 U.S.C. Chapter 35). To request a copy of these
documents, call the SAMHSA Reports Clearance Officer on (240) 276-1243.
Project: Mandatory Guidelines for Federal Workplace Drug Testing
Programs (OMB No. 0930-0158)--Revision
SAMHSA's Mandatory Guidelines for Federal Workplace Drug Testing
Programs will request OMB approval for the Federal Drug Testing Custody
and Control Form for Federal agency and federally regulated drug
testing programs which must comply with the HHS Mandatory Guidelines
for Federal Workplace Drug Testing Programs (73 FR 71858) dated
November 25, 2008, and for the information provided by laboratories for
the National Laboratory Certification Program (NLCP).
The Federal Drug Testing Custody and Control Form (Federal CCF) is
used by all Federal agencies and employers regulated by the Department
of Transportation to document the collection and chain of custody of
urine specimens at the collection site, for laboratories to report
results, and for Medical Review Officers to make a determination. The
current Federal CCF approved by OMB has a November 30, 2011 expiration
date. SAMHSA has resubmitted the Federal CCF with revisions to the form
for OMB approval.
The first change is to add a new item in Step 1 of Copy 1,
which lists the acronyms for the Federal testing authorities under
which the specimen is collected. The new Step 1 (d) would read as
follows: ``D. Specify Testing Authority: HHS, NRC, DOT--Specify DOT
Agency: FMCSA, FAA, FRA, FTA, PHMSA, USCG'' with a checkbox beside each
agency name.
The second change is to revise the Federal CCF Copy 1 to
permit use by Instrumented Initial Test Facility (IITF), in addition to
laboratories.
The third change is to add the new drug analytes required
by the revised Guidelines to the Primary Specimen Report section in
Step 5(a) on Copy 1. The new drug analytes are
methylenedioxymethamphetamine (MDMA), commonly known as ``ecstasy'';
methyleneamphetamine (MDA), and methylenedioxyethylamphetamine (MDEA).
MDA and MDEA are both close chemical analogues of MDMA.
The fourth change is to revise the Medical Review Officer
(MRO) reporting sections on Copy 2 for primary specimens (Step 6) and
for split specimens (Step 7) to facilitate reporting in accordance with
the Guidelines.
Below is a copy of the revised Federal CCF:
BILLING CODE 4162-20-P
[[Page 41489]]
[GRAPHIC] [TIFF OMITTED] TN16JY10.028
[[Page 41490]]
[GRAPHIC] [TIFF OMITTED] TN16JY10.029
[[Page 41491]]
[GRAPHIC] [TIFF OMITTED] TN16JY10.030
[[Page 41492]]
[GRAPHIC] [TIFF OMITTED] TN16JY10.031
[[Page 41493]]
[GRAPHIC] [TIFF OMITTED] TN16JY10.032
[[Page 41494]]
[GRAPHIC] [TIFF OMITTED] TN16JY10.033
[[Page 41495]]
[GRAPHIC] [TIFF OMITTED] TN16JY10.034
[[Page 41496]]
[GRAPHIC] [TIFF OMITTED] TN16JY10.035
[[Page 41497]]
[GRAPHIC] [TIFF OMITTED] TN16JY10.036
BILLING CODE 4162-20-C
Prior to an inspection, a laboratory is required to submit specific
information regarding its laboratory procedures. Collecting this
information prior to an inspection allows the inspectors to thoroughly
review and understand the laboratory's testing procedures before
arriving at the laboratory.
The annual total burden estimates for the Federal Drug Testing
Custody and Control Form, the NLCP application, the NLCP inspection
checklist, and NLCP recordkeeping requirements are shown in the
following table.
----------------------------------------------------------------------------------------------------------------
Burden/
Form/respondent response Number of Total annual
(hrs.) responses burden (hrs.)
----------------------------------------------------------------------------------------------------------------
Custody and Control Form:
Donor....................................................... .08 7,096,000 567,680
Collector................................................... .07 7,096,000 496,720
Laboratory.................................................. .05 7,096,000 354,800
Medical Review Officer...................................... .05 7,096,000 354,800
Laboratory Application.......................................... 3.00 3 9
Laboratory Inspection Checklist................................. 3.00 100 300
Laboratory Recordkeeping........................................ 250.00 50 12,500
-----------------------------------------------
Total................................................... .............. .............. 1,786,809
----------------------------------------------------------------------------------------------------------------
Written comments and recommendations concerning the proposed
information collection should be sent by August 16, 2010 to: SAMHSA
Desk Officer, Human Resources and Housing Branch, Office of Management
and Budget, New Executive Office Building, Room 10235, Washington, DC
20503; due to potential delays in OMB's receipt and processing of mail
sent through the U.S. Postal Service, respondents are encouraged to
submit comments by fax to: 202-395-6974.
Dated: July 12, 2010.
Dennis O. Romero,
Deputy Director, Office of Program Services.
[FR Doc. 2010-17400 Filed 7-15-10; 8:45 am]
BILLING CODE 4162-20-P